SLR going into the ASX 300 is handy as will provide some institutional buying to take out DRM retail selling pressure.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025